Prosecution Insights
Last updated: August 18, 2026

Examiner: REDWOOD, CHRISTOPHER EVAN

Tech Center 1600 • Art Units: 1629

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate
-60.0% vs TC avg
16
Total Applications
Interview Lift
0
Avg Prosecution Days
Based on 0 resolved cases, 2023–2026

Rejection Statute Breakdown

2.7%
§101 Eligibility
16.4%
§102 Novelty
42.5%
§103 Obviousness
20.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18682505 2,2-DIFLUORO-5H-[1,3]DIOXOLO[4,5-F]ISOINDOL-7-ONE DERIVATIVES AS PESTICIDES Non-Final OA SYNGENTA CROP PROTECTION AG
18695637 ANTIBACTERIAL COMPOSITION Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18266096 NOVEL METHODS Non-Final OA The Trustees of the University of Pennsylvania
18307522 Methods of Treating Cystic Fibrosis Non-Final OA The Trustees of Dartmouth College
18666911 COMBINATION TREATMENT AND/OR PREVENTION OF CARDIAC DISEASES IN NON-HUMAN MAMMALS COMPRISING ONE OR MORE SGLT-2 INHIBITORS AND PIMOBENDAN AND/OR TELMISARTAN Non-Final OA BOEHRINGER INGELHEIM VETMEDICA GMBH
18705620 Prevention and treatment of osteoarticular diseases by inhibiting acetylcholinesterase Non-Final OA THE HONG KONG POLYTECHNIC UNIVERSITY

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month